- Global Pharma News & Resources

iotaSciences Launches New isoPick™ Single-Cell Picker to Further Expand Handling Solutions for Efficient Cell Biology & Gene Therapy Applications

First isoPick showcases at upcoming ELRIG CRISPR IN DRUG DISCOVERY 2023 event in Oxford (UK) and SLAS 2023 meeting in San Diego (USA)

OXFORD, UK, February 06, 2023 / B3C newswire / -- iotaSciences, a spin-out from Oxford University in the field of single-cell handling solutions announced today product development completion for its newly built single cell picker instrumentation isoPick™. isoPick™ represents a powerful addition to iotaSciences´ existing product portfolio for single-cell handling solutions based on its proprietary fluid-shaping technology. The product portfolio comprises instruments for automatic isolation, feeding and harvesting of cells (isoCell) as well as verification and documentation of monoclonality and tracking of respectively derived cell clones (isoHub™).

The new isoPick instrument ensures temperature-controlled ultra-gentle handling of single cells during isolation and picking through a simple workflow guided by highly intuitive and user-friendly touchscreen interfaces. Like iotaSciences´ other solutions the isoPick is a small footprint instrument with low maintenance need. Those features should translate well into tangible user benefits for cell & gene therapy researchers and the wider single cell research community with an easy-to-use end-to-end solution for verifiable isolation of single cells where high cell viability and single-cell outgrowth is maintained.

First applications have been successfully developed related to whole genome-amplification of single cells or single-cell genomics, as well as human induced pluripotent stem cells (hiPSC)-based cell-line engineering.

iotaSciences’ Chief Business Officer Alexander Feuerborn commented: “We are highly excited about the availability of the isoPick instrument in order to extend our existing portfolio of single-cell handling solutions. This should help to further drive the growing installed base of iotaSciences´ solutions in customer labs in Europe, the U.S and Asia“.

iotaSciences will showcase its new isoPick™ system for the first time at the upcoming ELRIG CRISPR IN DRUG DISCOVERY 2023 event in Oxford (UK) from February 7-8, 2023 and more internationally at the SLAS2023 conference in San Diego (USA) from February 25 – March 1, 2023.


About iotaSciences
iotaSciences is a spin-out from Oxford University (UK) which was founded in 2016 by scientists from the Department of Engineering Science and the Sir William Dunn School of Pathology. Since its inception, iotaSciences has been committed to offer researchers highly user-friendly, reliable, and powerful single cell handling technologies and solutions with unique capabilities that greatly simplify and facilitate breakthrough advances in cell biology and gene therapy.



iotaSciences Ltd.
Dr. Alexander Feuerborn, Chief Business Officer
+44 (1865) 309630

Keywords: Genomics; Documentation; Cell Biology; Genetic Therapy; Single-Cell Analysis; Cell Separation; Cell Engineering; Induced Pluripotent Stem Cells; Cell Survival; Temperature; Clone Cells; Equipment and Supplies; Research; United Kingdom;

Published by B3C newswire

Editor Details

Last Updated: 06-Feb-2023